Treatment of Cancer using a Specific Combination of Drugs

FOI REFERENCE: 24411 FOI DATE: 8^th October 2024       

1) In the past 6 months, at your trust how many patients were treated with a combination of Dabrafenib + Trametinib for the following conditions:

A) Metastatic Melanoma —   0 patients

B) Adjuvant Melanoma —    6 patients

C) BRAF mutated Lung Cancer — 0 patients

2) In the past 6 months, at your trust how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following conditions:

A) Metastatic Melanoma — 0 patients

B) Colorectal Cancer — 0 patients